RFS
LAB icon

Retirement Financial Solutions’s Standard BioTools LAB Stock Holding History

Retirement Financial Solutions’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-319
Closed -$373 – 150
2022
Q4 		$373 Buy
+319
New +$393 ﹤0.01% 271

Other funds holding LAB

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Retirement Financial Solutions's LAB Position: Q1 2023 in Review

Retirement Financial Solutions sold out of Standard BioTools (LAB) in Q1 2023, closing a stake of 319 shares — an estimated $373 sold.

Retirement Financial Solutions first reported a position in LAB in Q4 2022 and held it in 1 quarter. The position peaked at $373 in Q4 2022. 69 funds tracked by Wall St. Rank hold LAB as of Q1 2023.

  • Retirement Financial Solutions reported no remaining Standard BioTools position as of Q1 2023 after selling out during the quarter.
  • Retirement Financial Solutions sold 319 Standard BioTools shares in Q1 2023, an estimated $373.
  • Retirement Financial Solutions first reported a position in Standard BioTools in Q4 2022 and held it in 1 quarter.
  • Retirement Financial Solutions's Standard BioTools position peaked at $373 in Q4 2022.
  • 69 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2023.

Based on Retirement Financial Solutions's 13F filing for Q1 2023, filed 26 Apr 2023.